This document provides an overview of Sneha Kalpana, the Ayurvedic process of preparing medicated oils and ghees. It defines Sneha Kalpana, discusses the types of bases used like ghee and oils, and the aims of the process. Key steps in the general method of preparation are outlined, including rules for ingredients proportions. Signs of proper maturation and characteristics of the final products are also described. Various techniques like Murchana, Avartana, and using rasa drugs are summarized.
Sandhāna Kalpana is an Alcoholic or Acidic Medicinal preparations of Ayurvedic Pharmaceuticals, It involves the process of fermentation where the 'dravadravya' (kwātha, swarasa or liquid preparation), 'madhura dravya' (jaggery, honey or sugar), 'praksepa dravya' (fine powders of medicinal drugs) and 'sandhäna dravya' (dhātaki puspa, madhuka puspa as fermentation initiators) are put together in an inert vessel (mud pot) and sealed for a specified time period to facilitate the process of fermentation Madhya (Alcoholic) and Shukti (Acedic) are the two basic types of this process
This is the second part of presentation regarding definitions in Rasa shastra. An attempt is made to clarify the definitions in more clear way also useful images are added to further improvise the presentation.
Sandhāna Kalpana is an Alcoholic or Acidic Medicinal preparations of Ayurvedic Pharmaceuticals, It involves the process of fermentation where the 'dravadravya' (kwātha, swarasa or liquid preparation), 'madhura dravya' (jaggery, honey or sugar), 'praksepa dravya' (fine powders of medicinal drugs) and 'sandhäna dravya' (dhātaki puspa, madhuka puspa as fermentation initiators) are put together in an inert vessel (mud pot) and sealed for a specified time period to facilitate the process of fermentation Madhya (Alcoholic) and Shukti (Acedic) are the two basic types of this process
This is the second part of presentation regarding definitions in Rasa shastra. An attempt is made to clarify the definitions in more clear way also useful images are added to further improvise the presentation.
Sandhana kalpana is the preparation of self generated alcohol. All the preparations that are resulting from FERMENTATION procedure come under SANDHANA KALPANA.
Sandhana kalpana is a special technique to prepare most effective medicines like Asava and Aristas. The medicines prepared through Sandhana kriya are quick in action, long shelf life, palatability and has nutritive value.The self-generated alcohol is the key factor behind the success of Sandhana kalpana.
For a rasa Shastra student its necessary to have knowledge of Parada Bandhas. In this presentation bandhas are explained according to various authors and detailed description is narrated according to Rasa Ratna Samucchaya the most accepted book of Rasa Shastra. I hope this presentation will help the students of Rasa Shastra in having better summarised knowledge of bandhas.
Vipaka comes under the five concepts under the study of a dravya (Rasapanchakas). In Ayurveda the digestion & metabolism of any substance is explained in two stages:
Avasthapaka
Nishtapaka
Avasthapaka is the first phase considered as digestion.
In charaka the word “prapaka” is used as the synonym for avasthapaka.
Nishtapka or Vipaka is the second phase and considered as metabolism.
the ppt gives detailed knowledge of Karma that are described in Ayurveda Dravyaguna (Ayurvedic Materia medica) it is useful to treat the patients by Ayurvedic way.
this is a practical presentation of Trinetra rasa.this ppt includes various references , quantity of the ingredients , video of method of preparation,market availability, research works done .
Sandhana kalpana is the preparation of self generated alcohol. All the preparations that are resulting from FERMENTATION procedure come under SANDHANA KALPANA.
Sandhana kalpana is a special technique to prepare most effective medicines like Asava and Aristas. The medicines prepared through Sandhana kriya are quick in action, long shelf life, palatability and has nutritive value.The self-generated alcohol is the key factor behind the success of Sandhana kalpana.
For a rasa Shastra student its necessary to have knowledge of Parada Bandhas. In this presentation bandhas are explained according to various authors and detailed description is narrated according to Rasa Ratna Samucchaya the most accepted book of Rasa Shastra. I hope this presentation will help the students of Rasa Shastra in having better summarised knowledge of bandhas.
Vipaka comes under the five concepts under the study of a dravya (Rasapanchakas). In Ayurveda the digestion & metabolism of any substance is explained in two stages:
Avasthapaka
Nishtapaka
Avasthapaka is the first phase considered as digestion.
In charaka the word “prapaka” is used as the synonym for avasthapaka.
Nishtapka or Vipaka is the second phase and considered as metabolism.
the ppt gives detailed knowledge of Karma that are described in Ayurveda Dravyaguna (Ayurvedic Materia medica) it is useful to treat the patients by Ayurvedic way.
this is a practical presentation of Trinetra rasa.this ppt includes various references , quantity of the ingredients , video of method of preparation,market availability, research works done .
Ksheerabala Taila is a classical ayurvedic medicine manufactured using Bala, Milk and Tila taila which helps in conditions like sciatica, arthritis, lowbackache, cervical spondylosis, facial paralysis and as a rasayana (rejuvenation).
this is an ppt presentation by dr.b.arun kumar, who is working as a lecturer in MNR ayurvedic medical college, sangareddy, near hyderabad. in this presentation i given all details of virechana karma.
Rasa sastra is one of the important branch of Ayurveda which deals with mineral and
herbomineral pharmaceutical preparations like kharliya rasayana, parpati rasayana,
kupipakva rasayana and pottali rasayana. Pottali rasayana is one among rasa aushadhi
which is very effective and also known as emergency medicine. Pottali rasayana prepared
by different method. Here we prepare with gandhak drava swedana method. The process of
pottali kalpana is very unique, and from other dosage forms it has qualities like small dose,
very high potency, easy to handle, and maximum shelf life. In Hemagarbha pottali rasa main
drugs are suddha parad, suddha gandhak, tamra bhasma and swarna bhasma which gives
compact form by bhavna with kumari swarwsa. In this article we attempted to described
different methods of preparation and regarding pharmaceutical process of Hemagarbha pottali rasa in detail & Clinical Aspects .
Charak & 50 Mahakashay – Part 1 – By Prof.Dr.R.R.deshpande
• This Topic is very Popular in Ayurvedic field .This 50 Groups are like Readyrecknor or Practical Prescriber for Ayurvedic Medical Practice. This Topic is a part of Syllabus in 2 subjects of BAMS course –1) Dravyaguna vignyan ( Paper 1 Part A ,Point 10 –Dashemani Gan 2) Charak Purvardha ( Charak Sutrasthan ,Chaper 4 –Shadvirechan Shatiya) .Each group consists of 10 Herbs .So 50 x 10 = 500 Herbs .But unfortunately many Herbs are controversial & many are not available .Students will easily now note ,which plants are not available from this PPT .Also this PPT will explain the Pharmacodynamics of these herbs .So students by their own intelligence can add other herbs also in this Group
• Visit – www.ayurvedicfriend.com
Phone – 9226810630
Dravyaguna part 1 By Prof.Dr.R.R.Deshpande & Dr.Ila Bhorrajendra deshpande
This ppt is prepared & uploaded by Prof.dr.R.R.Deshpande & Dr.Ila Bhor .This ppt is very useful for Ayurvedic Students .This includes raw & wet Herbs with nice photos & information of their properties ,Uses & products.This ppt is a part of Pack of 7 PPTS .So viewers must also see Dravyaguna Part 1 to 7 .Please feel free to discuss any thing to us on 922 68 10 630 or 9423211003
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
3. GIST OF TOPIC
INTRODUCTION
DEFINITION, TYPES
AIMS OF SNEHA
KALPANA
GENERAL METHOD OF
PREPARATION
7 RULES OF KALPANA
SNEHA PAKA AND
SIDDHI LAXANAS
MURCHANA
AVARTANA
SNEHA KALPANA
WITH RASA DRAVYAS
SNEHA KALPANA IN
SDM TEACHING
PHARMACY
DISCUSSION
CONCLUSION
Dr.KISHORE 3
4. INTRODUCTION
• Derivation – स्निह् प्रीतौ
• Sneha Fat or Fatty material
• Kalpana Pharmaceutical process of
medicaments
• Eg: Ghrita kalpana and Taila kalpana
• Produces snigdhata to the body
Dr.KISHORE 4
6. DEFINITION
• Ghritas are preparations in which ghee is boiled with
prescribed Kashayas (decoctions) and kalkas of drugs
according to the formula. This process ensures
absorption of the active therapeutic principles of the
ingredients used
• Tailas are preparations in which taila is boiled with
prescribed Kashayas (decoction) and kalkas of drugs
according to the formula. This process ensures
absorption of the active therapeutic properties of the
ingredients used.
Dr.KISHORE 6
Ref--AFI
9. AIMS OF SNEHA KALPANA
• The rationality behind taking an Taila / Ghrita as
a base is presumably –
• To Extract water soluble, lipid soluble active
fractions from the ingredients used
• To Enhance Shelf life
• To Enhance the Drug Absorption
Dr.KISHORE 9
14. PREPARATION OF KWATHA FOR SNEHA
KALPANA
1 PART
DRUG
4
PARTS
WATER
1/4
Dr.KISHORE 14Ref—Sha Ma /9/2
15. BASED ON NATURE OF DRUG
MADHYAMA
AND
KATINA
DRAVYA
4
8
16
PARTS
Dr.KISHORE 15Ref—Sha Ma /9/3
16. BASED ON QUANTITY OF DRUG
• ONE
KARSHA
(12g )
• ONE
PALA (48
g)
• ONE
PALA
(48g)
• ONE
KUDAVA
(192 g)
• ONE
KUDAVA
(192 g)
• ONE
KHARI
(196.5 KG
APPRX)
16
PARTS
8
PARTS
4
PARTS
Drug
Water
Dr.KISHORE 16
Ref—Sha Ma /9/4
21. Drava dravyas like
Kalka is 1/8 th part of sneha add 4 parts of water
1/8:1:4
DUGDHA
DHADHI
MAMSARASA
TAKRA
Dr.KISHORE 21
?
22. EXAMPLES
DUGDHA
Go Dugdha Aja Dugdha
Kumkumadi Taila Anu Taila
• DADHI Kottam Chukkadhi Taila
• TAKRA Grahanimihira Taila
• MAMSA RASA Sambukadya Taila
Dr.KISHORE 22Ref—A.F.I
23. • GHRITAS with MAMSA RASA
AMRITHA PRASHA GHRITA
BRIHATH CHAAGALYADHI
GRITHA
BRIHAT ASWAGANDHA GHRITA
GO DUGDA
AMRITHA BHALLATAKA GHRITA
KSHIRA SHATPHALA GHRITA
Dr.KISHORE 23Ref—A.F.I
24. • If 4 or less they have to be four times to the
quantity of sneha in total
• If drava dravyas are 5 or more in number then
each one should be taken equal to that of sneha
Dr.KISHORE 24
?
25. EXAMPLES
• NILI BRINGADI TAILA
DRAVA DRAVYAS are
NILI SWARASA
BRINGARAJA SWARASA
AJA KSHIRA
NARIKELA KSHIRA
MAHISHI KSHIRA
GO DUGDA
6
Dr.KISHORE 25Ref—A.F.I
26. KALKA DRAVYA AND SNEHA
Then DRAVA DRAVYA WATER
¼:1:4
Dr.KISHORE 26
?
27. EXAMPLES
• WATER as DRAVA DRAVYA in
CHITRAKADI TAILA
PINDA TAILA
Dr.KISHORE 27Ref—A.F.I
28. • KALKA
(Kwatha dravyas are used as Kalka dravya)
• Only Sneha and KWATHA
1/6:1:4
Dr.KISHORE 28
?
34. SNEHA PAAKA KAALA
• The Duration of Paka period depends on the
nature of the Drava dravyas added to Sneha.
• Valli , Moola - 12 days
• Kwatha, Aranala and Takra - 5 days
• Swarasa - 3 days
• Dugdha - 2 days
• Mamsa rasa, Vrihi dhanya - 1 day
Dr.KISHORE
34Ref—B.R/1/1310-1312
38. SNEHA PAKA
आम िाक र्िवीयि अस्ग्िमातध्य गुु
मॄदु िाक िनय कमि
मध्यम िाक सवि कमि
खर िाक अभ्यड़गार्थं
दग्ध िाक दाह् , र्िश्प्रयोजि
Dr.KISHORE 38Ref—Sha Ma /9/17
39. HOW TO ASSESS PAKA
• Ama paka Apari Paka
• Mridu paka Less quantity of Moisture in Kalka
• Madhayama paka Soft but devoid of moisture
• Khara paka Slightly rough to touch
• Dagdha paka Katina Tara Sneha kalka
Dr.KISHORE 39
41. ADITYA PAKA
Dravya + Sneha
appropriate paatra
ADITYA PAKA
EXAMPLE
KASISADI GHRITA
Kasisa Nisha Musta etc., drugs
are taken in quantity of 1 Karsha
and powdered
30 Pala of GHRITA
kept in TAMRA PAATRA
Exposed to SUN for 7 days
Dr.KISHORE 41Ref—Sha Ma /9/51-57
42. GANDHA PAKA
• Drugs are taken in equal quantity and
powdered thoroughly and packed in cotton
cloth
• Taila is to be taken about 16 times to that of
drugs powder
• When Taila is boiled, the Pottali is immersed
in the Taila and vessel is closed
• Its immersed for Ten days then the pottali is to
be squeezed properly to obtain GANDHA
PAKA
Dr.KISHORE 42Ref—B.R/5/1309
43. MURCHANA
• Sneha is subjected to one particular samskara
called Sneha murchana.
• Applicable for both Ghrita and Taila.
• Durgandha vinahanthi, Ama dosha harathi
• Veeryavan , Soukhya dhaayi
Dr.KISHORE 43Ref—B.R/5/1285
45. TILA TAILA MURCHANA
Manjishta
Rajani , Lodhra
Musta, Nalika
Triphala, Bala
Vatankura, Suchi
Pushpa mula rasa
TILA
TAILA
JALA
M
U
R
C
H
I
T
H
A
T
I
L
A
T
A
I
L
A
1/16 Parts
1/64
Parts
1 Part
4 Parts
Dr.KISHORE 45Ref—A.F.I
46. QUALITIES OF MURCHITHA SNEHA
• Significant increase in Iodine and Saponification
values
• Decrease in the Acid value
• Decrease in the Rancidity
• Decrease in the Saturated acid profile and increase in
the Unsaturation Percentage
Dr.KISHORE 46
Standardization of Tila taila (Sesamum oil) - An Ingredient used in
the Ayurvedic Vaitarana Basti
Dr. Sriram Chandra Mishra, Dr. Narayan Chandra Dash.
Department of Kayachikitsa, Gopabandhu Ayurveda Mahavidyalaya, Puri, Odisha
47. WHY TILA TAILA IS BEST
• LIGNANS
Acts as anti cholesterol agents
• SESAMIN
Protects liver from the oxidative damage
Dr.KISHORE 47
48. AVARTANA
• Repeating the process (sneha kalpana)
for several times means Avartana
• This potentiates the final product; to
achieve the maximum benefit of the
drug
Dr.KISHORE 48Ref—CHA.CHI.29/117-120
49. METHOD OF PREPARATION
• The general procedure of Sneha kalpana is
followed to obtain sneha
• Kalka and Drava dravya are added for second
Avarthy and Sneha paka is done
• Number of such repetitions would determine
the number of AVARTANA
• Variation in consistency, colour and odour of
the product may be observed after each
Avartana
Dr.KISHORE 49
50. EXAMPLES OF AVARTAYUKTA
SNEHA KALPANAS
• KSHEERA BALA TAILA 101
• DHANWANTARAM TAILA 101
Dr.KISHORE 50
PHARMACEUTICAL STUDY OF AVARTITA
HINGUSAUVARCHALADI GHRITA
Roshy Joseph C, Ilanchezhian R
51. KUZHAMBU
• Kerala Pharmacies are using Kuzhambu
practically in Sneha kalpana
• To get more Vatahara action than the Taila by
adding Eranda taila, etc.
• By doing this procedure viscosity of the Sneha
will increase
• There will be no change in the ingredients but only
in the Sneha dravya
Dr.KISHORE 51
56. RESEARCH WORKS
• PHARMACEUTICO ANALYTICAL STUDY OF SNEHA
PAKA SAMAYA W.S.R. BRAHMI GRITHA AND ITS
EFFECT ON MEMORY IN ALBINO RATS
SARAN BABU ; SDMCA, HASSAN
• CHEMICAL ANALYSIS OF NIRGUNDI TAILA W.S.R.TO
PREPARE IN DIFFERENT NUMBER OF DAYS
• PRASHANTH BK RAO K SHANKAR
Dr.KISHORE 56
57. DISCUSSION
• Kalpana in which Agni, Jala and Kaala
samskaras are used to obtain active principles
is Sneha kalpana
• Unique procedure to extract both water and
lipid soluble active principles
• It is administered by different routes as Bahya
and Abhyantara
• Madhyama paka is considered as Sarva karma
yukta
Dr.KISHORE 57
58. CONTD…..
• Murchana plays an important role in Pharmaceutics
and Therapeutics
• Avartana increases potency of the product
• Viscosity of Kuzhambu is more than normal Taila
because of more Sneha dravyas incorporated
• Rules are set for complete or proper extraction of
gunas (active principles) into Sneha
Dr.KISHORE 58
59. CONCLUSION
• Sneha kalpana is widely used dosage form in
Ayurvedic pharmaceutics
• Method of preparation and rules are explained to
acquire the complete efficacy of the drugs
employed
• More research needs to be done to revalidate the
concepts explained
Dr.KISHORE 59
60. Dr.KISHORE 60
• VAIDHYAKA SHABDHA SINDHU
• AYURVEDIC FORMULARY OF INDIA
• SHARANGADHARA SAMHITHA
• ASHTANGA HRIDAYAM CHIKITSA STHANAM
• BHAISHAJYA RATNAVALI
• SAHASRA YOGAM
• AN EXTENSIVE CHEMICALAND
CHROMATOGRAPHICAL ANALYSIS OF
AMURCHITHA, MURCHITHAAND
AUSHADHA SIDDHA TAILAS PREPARED
WITH AMURCHITHA AND MURCHITHA
TAILAS, HIREMATH B
REFERENCES
